Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
Clinical trial NCT00220402 · COMPLETED
Trial details
- NCT number
- NCT00220402
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2007-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.